Login / Signup

ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis.

Pierre Quartier Dit MaireAmandine BaptisteVéronique DespertEmma Allain-LaunayIsabelle Koné-PautAlexandre BelotLaurent KodjikianDominique MonnetMichel WeberCaroline ElieBahram Bodaghinull null
Published in: Annals of the rheumatic diseases (2017)
NCT01385826.
Keyphrases
  • juvenile idiopathic arthritis
  • early onset
  • double blind
  • late onset
  • study protocol
  • clinical trial
  • placebo controlled
  • open label
  • disease activity
  • randomized controlled trial
  • drug induced
  • ankylosing spondylitis